Distance Insect Growth Regulator

SECTION 2: Hazards identification

Emergency Overview Caution • Causes skin and eye irritation. • Harmful if swallowed, inhaled or absorbed through skin

Aspiration hazard

do not induce vomiting • Avoid breathing vapors or spray mist. • Do not get in eyes, on skin or on clothing • Keep out of reach of children

Potential health effects

Acute Toxicity (Primary Routes of Exposure): None known Acute Eye Contact: This product can cause brief and/or minor eye irritation. The expected adverse health effects resulting from an exposure may include redness and possible swelling. Acute Skin Contact: This product can cause moderate skin irritation. The expected adverse health effects resulting from an exposure may include redness and swelling. This product is not expected to cause allergic skin reactions. This product is slightly toxic when absorbed through the skin. Acute Ingestion: This product is slightly toxic when ingested. Ingestion of this product may cause gastrointestinal irritation, nausea, vomiting and diarrhea. Because of the low viscosity of this substance, it can directly enter the lungs if it is swallowed (this is called aspiration). This can occur during the act of swallowing or when vomiting the substance. Once in the lungs, the substance is very difficult to remove and can cause injury to the lungs and death. Acute Inhalation: This product is minimally toxic when inhaled. Exposure to high concentrations in the air may result in respiratory irritation. Signs and symptoms may include, but not be limited to, nasal discharge, sore throat, coughing and difficulty in breathing. Chronic Toxicity (including cancer): Repeated high exposures to Pyriproxyfen Technical produced changes in the liver, kidney and red blood cells but did not produce cancer in test animals. Prolonged or repeated dermal exposures may cause drying, scaling and even blistering of the skin. Reports have associated repeated and prolonged occupational overexposure to solvents with permanent brain and nervous system damage. Symptoms include fatigue, concentration difficulties, anxiety, depression, rapid mood swings and short-term memory loss. The reports are not clear with regard to the types of solvents that may cause these symptoms, and there is controversy among scientists to whether the condition exists or is caused by this type of product. Since many other diseases cause some or all of these conditions, a doctor should be consulted if any appear. This product contains naphthalene which has been listed by the International Agency for Research on Cancer (IARC) as possibly carcinogenic to humans (Group 2B). Developmental Toxicity (birth defects): No developmental toxicity was produced in animals exposed to Pyriproxyfen Technical, even at doses that were toxic to the pregnant animal. Reproductive toxicity: Pyriproxyfen Technical did not produce reproductive toxicity in animal studies. Signs and Symptoms of Systemic Effects: The acute toxicity of this product is relatively low; transient, minimal signs of toxicity were observed in animals at high oral doses. This product contains a solvent mixture. Solvents, when inhaled, can cause nasal and respiratory irritation and central nervous system effects including dizziness, weakness, fatigue, nausea, headache and possibly unconsciousness and even death. Ingestion of solvents can cause gastrointestinal irritation, nausea, vomiting and diarrhea. Aspiration of low viscosity solvents can cause chemical pneumonitis which can be fatal. Potentially Aggravated Medical Conditions: Individuals with preexisting diseases of the liver, kidney, red blood cell or central nervous system may have increased susceptibility to the toxicity of excessive exposures. For complete discussion of the toxicology data from which this evaluation was made, refer to Section 11. For Ecotox/Environmental Information, refer to Section 12. For Regulatory Information, refer to Section 15.